Albania National action plan against anti-microbial resistance (NAP-AMR).
Country
Type of law
Policy
Abstract
This Albania National action plan against anti-microbial resistance (NAP-AMR) covers a period of 5 years (from the year 2018 until the year 2022). Albania is signatory to the resolution of the WHO General Assembly of October 5, 2016 on AntiMicrobial Resistance, that commits member states to the development of multi-sectoral National Action Plans against AMR. The Albania National action plan against anti-microbial resistance (NAP-AMR) realizes compliance with the relevant EU policies and accession criteria, including directives on AMR monitoring in zoonotic and indicator bacteria in food producing animals. works out explicit recommendations for AMR set in the Joint External evaluation of IHR core capacities of the Republic of Albania (September 2016) addresses several of the strategic objectives of the health chapter of the National Strategy for Development and Integration 2015-2020: 2.1, 2.6, 3.2, 3.6, 4.4, 4.5, 5.1, 5.6, is mentioned in the National Health Strategy 2016-2020 as one of the actions to fulfil the Strategy. Is congruent with the Law on Public Health of 2009 and the Law of Infectious Diseases of 2017. builds on Law No 15/2016: "On prevention and fight against infections and infectious diseases". builds on the Ministerial Order 551 of the Minister of Health of December 15, 2016, addressing a National Policy on AMR. is in synergy with National TB program.
Goals are as follows: To reduce human morbidity and mortality as a result of infections with micro-organisms that are resistant against antibiotics and other anti-microbial agents; To reduce health care costs that result from the lack of proper diagnostics, including microbiological tests, and from the use of ineffective treatments; To reduce loss of productivity in agriculture; To preserve the possibility of effective treatment of infections in humans and animals by reducing the emergence and spread of AMR and by developing new and effective antimicrobials. Currently, no representative data on the situation in Albania are available, in terms of morbidity and mortality of the population, presence of resistant strains of various micro-organisms and loss of production. Therefore, no quantitative targets for impact of the NAP-AMR can be set at present. The NAP-AMR includes the development of data collection and analysis to provide impact information in future. This text further addresses certain specific strategic objectives as follows: Enhance awareness, knowledge and understanding of infections and antimicrobial resistance through effective communication, education and training; Strengthen the knowledge and evidence base through surveillance and research; Reduce the incidence of infections through effective sanitation, hygiene and preventive measures; Optimize the use of antimicrobial medicines in human and animal health.
Anti-Microbial Resistance (AMR) is the development of resistance by micro-organisms (bacteria, viruses and fungus) to medicines like antibiotics (AB) and virus inhibitors. Worldwide, the emergence of AMR threatens the capacity of health and veterinary services to adequately prevent and treat infections, with as a result increase of morbidity and loss of human life, loss of production and economic value in agriculture and increase of costs of health services. The common interests and responsibilities of various sectors in society are captured under the name One Health : the health, agricultural, education and environmental sectors all have a stake and collaborate in the NAP-AMR.
Goals are as follows: To reduce human morbidity and mortality as a result of infections with micro-organisms that are resistant against antibiotics and other anti-microbial agents; To reduce health care costs that result from the lack of proper diagnostics, including microbiological tests, and from the use of ineffective treatments; To reduce loss of productivity in agriculture; To preserve the possibility of effective treatment of infections in humans and animals by reducing the emergence and spread of AMR and by developing new and effective antimicrobials. Currently, no representative data on the situation in Albania are available, in terms of morbidity and mortality of the population, presence of resistant strains of various micro-organisms and loss of production. Therefore, no quantitative targets for impact of the NAP-AMR can be set at present. The NAP-AMR includes the development of data collection and analysis to provide impact information in future. This text further addresses certain specific strategic objectives as follows: Enhance awareness, knowledge and understanding of infections and antimicrobial resistance through effective communication, education and training; Strengthen the knowledge and evidence base through surveillance and research; Reduce the incidence of infections through effective sanitation, hygiene and preventive measures; Optimize the use of antimicrobial medicines in human and animal health.
Anti-Microbial Resistance (AMR) is the development of resistance by micro-organisms (bacteria, viruses and fungus) to medicines like antibiotics (AB) and virus inhibitors. Worldwide, the emergence of AMR threatens the capacity of health and veterinary services to adequately prevent and treat infections, with as a result increase of morbidity and loss of human life, loss of production and economic value in agriculture and increase of costs of health services. The common interests and responsibilities of various sectors in society are captured under the name One Health : the health, agricultural, education and environmental sectors all have a stake and collaborate in the NAP-AMR.
Attached files
Web site
Date of text
Entry into force notes
This Albania National action plan against anti- microbial resistance (NAP-AMR) covers a period of 5 years (2018 2022).
Repealed
No
Source language
English
Legislation Amendment
No